Main Article Content
Introduction: Nigeria is one of the countries where maternal and neonatal tetanus is still prevalent and as such a public health issue. In spite of campaign on maternal tetanus immunization, its safety and protection against tetanus, uptake has remained poor.
Aim: This study is aimed to determine the level of Tetanus Toxoid (TT) vaccine uptake among women of child bearing age in Rivers State Nigeria.
Methods: Using a cluster sampling method, a descriptive cross-sectional community based study was carried out. The study was carried out in Opiro community in Igbo Agwuru-Asa Clan in Etche Local Government Area of Rivers State.
Results: Of the 555 women studied 108(19.5%) of them had received 5 doses of TT while 206 (37.1%) had received at least two doses of TT, giving an overall prevalence of TT utilization among women of childbearing age of 31.7%. Eighty four (31.2%) of women who were ≤ 30 years compared to the 122(42.7%) of the older women had received at least 2 doses of TT vaccine. This was statistically significant (P=0.005, OR 1.67, 95% CI 1.16-2.32), educational level, marital status and occupation also significantly affected Tetanus Toxoid vaccine uptake among the women.
Conclusion: This study concludes that utilization of TT immunization among women is low, that younger age, marital status, level of education and occupation of the women can significantly affect the level of TT uptake among women. There is need to strengthen immunization in this community and to create awareness on the need to get optimal Tetanus Toxoid immunization.
UNICEF document. Elimination of Maternal and Tetanus.
Owusu-Darko S, Diouf K, Nour NM. Elimination of maternal and neonatal tetanus: a 21st-century challenge. Rev Obstet Gynecol. 2012;5:151.
World Health Organization & UNICEF. Maternal and neonatal tetanus elimination by 2005: Strategies for achieving and maintaining elimination; 2002.
(Accessed 16th January 2020)
Dietz V, Milstien JB, van Loon F, Cochi S, Bennett J. Performance and potency of tetanus toxoid: Implications for eliminating neonatal tetanus. Bull WHO. 1996;74:619–28.
Stephen S. Arnon Tetanus (Clostridium tetani). In Kliegman RM, Stanton BF, Jenson HB, Behrman RE (eds.) Nelson Textbook of Pediatrics. 20th ed. Philadelphia: Elsevier Saunders. 2016; 1432.
[Accessed on 16th of December 2019]
Adovohekpe P, Onimisi A, Ekpemauzor C. Planning meeting on maternal and neonatal tetanus elimination in Nigeria. WHO Global Immunization News; 2013.
WHO: Global Burden of Disease. Update. Geneva, Switzerland: WHO; 2004.
Blencowe H, Lawn J, Vandelaer J, Roper M, Cousens S. Tetanus toxoid immunization to reduce mortality from neonatal tetanus. International Journal of Epidemiology. 2010;1:102–i9.
Maternal and Neonatal Tetanus Elimination- World Health.
Available:https://www.who.int › immunization › diseases › MNTE_initiative [Accessed on 16/01/2020]
Yaguo Ide LE, Uchenwa-Onyenegecha, TA. Tetanus in Nigeria: Is the end in sight? Greener Journal of Medical Sciences. 2015;2276-7797.
Aliyu AA, Dahiru T, Obiako RO, Amadu L, Biliaminu LB, Akase EI. Pattern and outcome of tetanus in a tertiary health facility in Northwest Nigeria. J Med Trop. 2017;19:1-5.
Alex-Hart BA, Okoh BAN. Awareness and status of tetanus toxoid vaccination among female undergraduate students in a Nigerian University. Int J Trop Dis Health. 2015;7(1):6-15.
Ridpath AD, Scobie HM, Shibeshi ME. Progress towards achieving and maintaining maternal and neonatal tetanus elimination in the African region. Pan Afr Med J. 2017;27:24.
Anatea MD, Mekonnen TH, Dachew BA. Determinants and perceptions of the utilization of tetanus toxoid immunization among reproductive-age women in Dukem Town, Eastern Ethiopia: A community-based cross-sectional study. BMC International Health and Human Rights. 2018;18:27.
Awosan KJ, Hassan M, Perception and utilization of tetanus toxoid immunization among pregnant women attending a tertiary centre in North-West Nigeria, Journal of Drug Delivery and Therapeutics. 2018;8(6):119-124.
Muhammad-Idris ZK, Shehu AU, Isa FM. Assessment of tetanus toxoid coverage among women of reproductive age in Kwarbai, Zaria. Arch Med Surg. 2017;2:48-54.
The Federal Republic of Nigeria. Nigeria Demographic and Health Survey; 2018.
[Accessed on 16th/12/ 2019]
Naeem M, Khan M, Abbas SH, Adil M, Khan A, Naz SM, Khan MU. Coverage and factors associated with tetanus toxoid vaccination among married women of reproductive age: A cross sectional study in Peshawar. J Ayub Med Coll Abbottabad. 2010;22:136–40.
Haile ZT, Chertok IRA, Teweldeberhan AK. Determinants of utilization of sufficient tetanus toxoid immunization during pregnancy: Evidence from the Kenya Demographic and Health Survey, 2008–2009. J Community Health. 2013;38:492–9.
Sule SS, Nkem-Nchendu C, Onajole AT, Ogunowo BE. Awareness, perception and coverage of tetanus immunization in women of child bearing age in an urban district of Lagos, Nigeria. Niger Postgrad Med J. 2014;21(2):107-14.
Madubuike G, Asuquo EO, Orji V. Perception of tetanus toxoid immunization among women in a Niger Delta community, Nigeria. Int J Trop Dis Health. 2017;23(3):1-8.
Naeem M, Khan MZ, Abbas SH, et al. Coverage, and factors associated with TT vaccination among married women of reproductive age, Peshawar Pakistan. Journal of Ayub Medical College. 2010; 22(3):136–140.
Muluken Dubale Mamoro, Lolemo Kelbiso Hanfore. Tetanus toxoid immunization status and associated factors among mothers in Damboya Woreda, Kembata Tembaro Zone, SNNP, Ethiopia. Journal of Nutrition and Metabolism. 2018;9.
[Accesseed on 18th of December 2019]
Singh S, Pallikadavath R, Ogollah W. Stones. Maternal tetanus toxoid vaccination and neonatal mortality in Rural North India,” PLoS One. 2012;7:11.
Bello AD, Aduroja PE. Assessment of tetanus toxoid vaccination awareness and uptake among women of reproductive age in Kwara State, Nigeria. Journal of Complementary and Alternative Medical Research. 2017;4(2):1-10.